1 min read

Abveris Beer: Back Again!

By Ryan Kelly on 12/23/20 7:36 AM

The Mabinator

MADE BY SCIENTISTS, FOR SCIENTISTS

BEST ENJOYED AFTER A LONG DAY in the lab

We teamed up with our neighbors at Castle Island Brewery to bring you more specialty beer that mAb scientists are sure to love! Our partners were so excited about our mAb Scientist IPA and Six Pack mAbs Lager we shipped over the summer that we decided to do it again!  

INTRODUCING:
THE MAB-INATOR Hoppy Session Ale

This beer is a session ale with killer taste.  Brewed with columbus and citra hops, it pairs well with anything. We're super excited about how it turned out!  We'll be contacting our partners to ship some of this beer out early 2021. 

 
Want to get your hands on the MAB-INATOR?
1) Follow Abveris on LinkedIn (click here)
2) leave an entertaining comment on our MAB-INATOR post. 
We'll select some of the best commenters and send you a 4-pack! 

For our active antibody discovery partners, we'll be reaching out to confirm shipping starting in 2021. 

Topics: Insider Events
3 min read

Abveris beer: Get It While It's cold!

By Ryan Kelly on 6/30/20 8:59 AM

Made by mAb scientists, for mAb scientists
BEST ENJOYED AFTER A LONG DAY IN THE LAB

We teamed up with our neighbors at Castle Island Brewery to bring you specialty beers that mAb scientists are sure to love! Introducing mAb Scientist IPA and Six Pack mAbs Lager. Our team designed some hilarious labels and the Castle Island team came through with some delicious lager and IPA options. 

We'll be sending out cases of beer to our partners, but we also recognize many of you are working from home right now. Click below to provide your address information for us to send you some free brews! 

BEER CALL: ADD ME TO THE LIST!

mAb Scientist IPA: OUR FLAGSHIP BEER
Abveris Beer Labels FINAL 2020-04-072 mab scientist

This beer is smooth but punchy; balanced yet intense. Despite the colossal amount of hops crammed into this beer, it’s still remarkably approachable for pros and rookies alike!

Our team held a naming competition for our flagship beer. After a close vote with many great names in the running, mAbScientist IPA rose to victory.  You may be asking: why does she have antibodies for hands? Fun fact: our monthly all-hands meeting is called "Monthly mAbs For Hands" after our all hands on approach to antibody discovery. 

MALTS: 2 ROW, VIENNA, CRYSTAL DEXTROSE

HOPS: SIMCOE, CASCADE

YEAST: HOUSE YEAST

Six Pack mAbs Lager: A SUMMER SPECIAL
Abveris Beer Labels FINAL 2020-04-07 six pack mabs

Whether you’re catching the game, conquering the trail, or walking in the door from your commute home, sometimes you just need a beer. Brewed distinctively for the everyday, this classic American Lager is light and crisp, and will have you reaching for another sip. So kick your feet up, breathe easy, and crack into a can of this liquid bliss."

This beer label speaks for itself. We all love the beach this time of the year, and we love showing off the muscles we've built while sitting on our butts all day at the biosafety cabinets. 

MALTS: PILSNER, BOHEMIAN WHEAT

HOPS: MAGNUM, RAKAU

YEAST: LAGER YEAST

About Abveris: 

Abveris is Boston's premier antibody discovery company providing contract research services to the biopharma industry. Abveris applies advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies to provide comprehensive gene-to-antibody discovery services. Abveris is developing the next generation of biologics, cell therapies, vaccines, and diagnostics in partnership with global leaders in biopharma. Additional information about Abveris is available at www.ABVERIS.com.

About Castle Island Brewery: 

Castle Island Brewery is based out of Norwood, Ma and can be found in fridges across New England. Their tasteful, easy to drink selection of beers is perfect for all beer drinkers from the beginner to the beer expert. Castle Island has their main staples, including the Keeper, American Lager, White Ale, and CandlePin but they are always making new exciting beers to keep up with their loyal customers evolving tastes! Check out more on their website: www.castleislandbeer.com

Topics: Insider Events
2 min read

FREE WEBINAR: High Throughput Antibody Discovery Targeting Cell Surface Receptors for Signaling Blocking in Cancer

By Travis LeGuyader on 4/14/20 3:11 PM

On-cell receptor functionality is a crucial threshold for drug development. By leveraging high content screening in antibody discovery workflows, you are able to improve the likelihood of campaign success at early stages of development. Join us for our webinar hosted by our COO Tracey Mullen and our friends at Sartorius, where Tracey will walk through a case study outlining how we incorporate this technology for antibody discovery projects targeting cell surface receptors. 

Tuesday, April 28, 2020, 11 am EDT

View on-demand webinar
 
Overview:

The use of monoclonal antibody-based therapeutics to target and treat cancer is considered to be one of the most successful therapeutic strategy within the oncology field to date. Specific cell surface antigen recognition is paramount to the success of these drugs, necessitating high resolution, early stage characterization of lead antibody drug candidates prior to preclinical development. In this webinar, Tracey Mullen, COO of Abveris, will review an antibody discovery campaign targeting a cell surface receptor implicated in cancer. Methods for immunization, antibody discovery, and subsequent functional characterization will be detailed.

Who Should Attend:
  • Antibody discovery scientists and researchers engaged in therapeutic drug discovery in oncology indications

  • Anyone interested in learning more about incorporating high-throughput flow cytometry analysis into early stage research and development

Speakers:
Tracey Mullen, Chief Operating Officer, Abveris

Tracey Mullen is a chemical-biological engineer from MIT who began her career as an Antibody Discovery Scientist at a startup contract research organization specializing in in vivo antibody discovery. In 2013, she joined the Antibody Discovery team at Biogen where she helped implement the technology transfer of the Adimab yeast display platform for antibody discovery and engineering. Throughout her tenure at Biogen, Tracey worked to optimize the in vitro discovery of antibodies to tough targets, including leveraging the Adimab platform to enerate antibodies against GPCRs. In June of 2018, Tracey joined Abveris Antibody as the Director of Antibody Discovery Operations, where she managed project design and development for in vivo discovery projects. She is now the Chief Operating Officer at AbX Biologics (formerly Abveris), a premium antibody discovery service partner boasting industry-leading timelines and cutting-edge technologies.

Carrie Haslam, Associate Editor, Select Science

Carrie Haslam is an Associate Editor at SelectScience, playing a key role in content production and specializing in Alzheimer’s disease and clinical diagnostics. She is finalizing her Ph.D. from Plymouth University, where she developed graphene-based biosensors for the early diagnosis of Alzheimer’s disease.

View on-demand webinar

Topics: Insider Service & Product Updates Events
2 min read

Free Webinar: Accelerating the antibody discovery workflow in the modern therapeutic landscape

By Ryan Kelly on 4/9/20 9:15 AM

How can we access greater antibody diversity through the plasma B cell repertoire? How can we down-select lead candidates in 1 day? Join Abveris and Berkeley Lights for an exclusive webinar opportunity to learn how we're redefining the boundaries of antibody discovery with the Berkeley Lights Beacon platform.

Tuesday, April 14, 2020, 11 am EDT

View on-demand Webinar
 
Overview:

As the complexity of therapeutic targets continues to evolve, more efficient and predictive identification of pertinent antibody candidates becomes increasingly valuable. Incorporating state-of-the-art, high-resolution discovery and antibody characterization tools like the Berkeley Lights platform into discovery workflows enables rapid and reliable selection of lead candidates more effectively than traditional techniques. Elucidating function early during screening and development can enhance candidate triage, as opposed to relying on brute-force methods to characterize large panels containing primarily non-functional clones. Optimization of the discovery platform using the Beacon instrument and case studies will be outlined.

Speakers:
Colby A. Souders, Ph.D., Chief Scientific Officer, Abveris

Colby holds a PhD in Cell and Molecular Biology from Texas A&M and has spent the last decade focused on antibody research. He first joined MassBiologics to lead discovery programs, develop platform technologies and advance monoclonal antibodies in the pipeline for the prevention, treatment or diagnosis of infectious and endogenous diseases. He later joined the Kanyos Bio Protein Engineering team to develop therapeutics based on a novel antigen-specific immune tolerance platform. In 2018 Colby joined Abveris Antibody with the goal as Chief Scientific Officer to usher in new antibody discovery tools and build a premium discovery engine.

Anupam Singhal, Ph.D., Product Manager, Antibody Therapeutics, Berkeley Lights

Anupam Singhal earned his PhD from the University of British Columbia and has over 15 years of experience in nanotechnology and microfluidics at UBC, the University of Toronto and Stanford University. His work has been cited over 600 times and resulted in several patents for molecular disease diagnosis, antibody discovery, and development of production cell-lines for biologics. At Berkeley Lights, Anupam leads the development of next-generation platforms for the discovery and development of antibody therapeutics.

View on-demand Webinar

Topics: Insider Service & Product Updates Events
1 min read

Hey, Boston & Cambridge!  We're hosting a free happy hour!

By Travis LeGuyader on 2/12/20 7:30 AM

Updated 3/6/20: Event cancelled due to concerns surrounding spread of COVID-19 virus. 
A note from the event organizers:
Thank you for your interest in our event, and we apologize that we must postpone the happy hour indefinitely due to concerns surrounding the spread of Covid-19 infection. 
We're proud to announce that we had over 100 attendees registered a week ahead of the event. When the time is right, we will announce a revised event date. 

Thursday | March 12 | 5:00-7:30 PM | Cambridge, MA

Open Bar & Free Appetizers

What is Brews & Biopharma?

A free happy hour for biopharma scientists.

An exclusive, relaxed event for biopharma scientists in the protein sciences. Finish your workday (and start your night) with us over casual drinks, appetizers, and networking.

Who is invited?

Scientists from our partner companies and their invited guests*

*We kindly ask you not to invite your professional recruiter or salesperson friends as your guests. Nobody likes to be pitched after work. Thank you for respecting our policy. 

Topics: Insider Events

Featured